Laurus Labs Q2 net profit surges 126% on CDMO and affordable medicines growth
Revenue rose 33% year over year to ₹2,206 crore. CDMO revenue climbed 75% over the same period.
BTC-3.56%
ETH-4.15%
SOL-5.90%
XRP-6.41%
USDC+0.10%
HYPE+12.10%
SUI-6.75%
TRX+5.58%BTC-3.56%ETH-4.15%SOL-5.90%XRP-6.41%USDC+0.10%HYPE+12.10%SUI-6.75%TRX+5.58%BTC-3.56%ETH-4.15%SOL-5.90%XRP-6.41%USDC+0.10%HYPE+12.10%SUI-6.75%TRX+5.58%BTC-3.56%ETH-4.15%SOL-5.90%XRP-6.41%USDC+0.10%HYPE+12.10%SUI-6.75%TRX+5.58%
